Biotech Stocks

US-listed biological-products companies: therapies derived from biological processes, distinct from small-molecule pharmaceutical manufacturers.

71 companies

Companies

Combined revenue

$96.44B

Median net margin

6.8%

Median P/E

19.8×

Company	Revenue	Net margin	P/E	Market cap
AMGEN INC (AMGN)	$36.75B	21.0%	27.2×	$236.86B
GILEAD SCIENCES, INC. (GILD)	$29.44B	28.9%	22.1×	$185.89B
BIOGEN INC. (BIIB)	$9.89B	13.1%	38.4×	$31.92B
NEUROCRINE BIOSCIENCES INC (NBIX)	$2.86B	16.7%	22.8×	$15.85B
EXELIXIS, INC. (EXEL)	$2.32B	33.7%	17.8×	$13.90B
QIAGEN N.V. (QGEN)	$2.09B	20.3%	21.9×	$8.90B
Moderna, Inc. (MRNA)	$1.94B	—	—	$61.59B
HALOZYME THERAPEUTICS, INC. (HALO)	$1.40B	22.7%	30.9×	$11.96B
BIO-TECHNE Corp (TECH)	$1.22B	15.0%	62.4×	$11.35B
NOVAVAX INC (NVAX)	$1.12B	39.2%	3.6×	$1.53B
BIOCRYST PHARMACEUTICALS INC (BCRX)	$874.8M	30.2%	8.2×	$2.52B
REPLIGEN CORP (RGEN)	$738.3M	6.6%	244.8×	$9.95B
ADMA BIOLOGICS, INC. (ADMA)	$510.2M	28.8%	13.3×	$2.09B
Tarsus Pharmaceuticals, Inc. (TARS)	$451.4M	-14.7%	—	$3.26B
Immunocore Holdings plc (IMCR)	$400.0M	-8.9%	—	$1.87B
Krystal Biotech, Inc. (KRYS)	$389.1M	52.6%	45.0×	$10.64B
Twist Bioscience Corp (TWST)	$376.6M	-20.6%	—	$9.15B
Adaptive Biotechnologies Corp (ADPT)	$277.0M	-21.5%	—	$3.98B
Vericel Corp (VCEL)	$276.3M	6.0%	90.3×	$2.17B
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)	$263.5M	—	—	$3.70B
Vaxart, Inc. (VXRT)	$237.3M	6.9%	2.9×	$121.6M
Adaptimmune Therapeutics PLC (ADAPY)	$178.0M	-39.8%	—	$7.2M
REGENXBIO Inc. (RGNX)	$170.4M	—	—	$637.7M
Ginkgo Bioworks Holdings, Inc. (DNA)	$170.2M	—	—	$466.7M
Beam Therapeutics Inc. (BEAM)	$139.7M	-57.2%	—	$3.03B
Monte Rosa Therapeutics, Inc. (GLUE)	$123.7M	-31.2%	—	$1.22B
Atara Biotherapeutics, Inc. (ATRA)	$120.8M	27.1%	3.6×	$94.2M
AGENUS INC (AGEN)	$114.2M	-2.7%	—	$351.5M
ImmunityBio, Inc. (IBRX)	$113.3M	—	—	$8.90B
Century Therapeutics, Inc. (IPSC)	$109.2M	-8.8%	—	$403.8M
SUTRO BIOPHARMA, INC. (STRO)	$102.5M	—	—	$339.1M
4D Molecular Therapeutics, Inc. (FDMT)	$85.2M	—	—	$792.8M
MeiraGTx Holdings plc (MGTX)	$81.4M	—	—	$1.36B
Autolus Therapeutics plc (AUTL)	$75.4M	—	—	$620.2M
RECURSION PHARMACEUTICALS, INC. (RXRX)	$74.7M	—	—	$1.79B
COMPUGEN LTD (CGEN)	$72.8M	48.6%	7.5×	$269.0M
Black Diamond Therapeutics, Inc. (BDTX)	$70.0M	32.0%	5.8×	$130.1M
Vir Biotechnology, Inc. (VIR)	$68.6M	—	—	$1.83B
CHAMPIONS ONCOLOGY, INC. (CSBR)	$59.4M	-2.0%	—	$68.4M
Invivyd, Inc. (IVVD)	$53.4M	-98.2%	—	$265.3M
Protalix BioTherapeutics, Inc. (PLX)	$52.7M	-12.5%	—	$204.7M
FENNEC PHARMACEUTICALS INC. (FENC)	$44.6M	-21.8%	—	$412.7M
Coherus Oncology, Inc. (CHRS)	$42.2M	—	1.0×	$224.0M
Editas Medicine, Inc. (EDIT)	$40.5M	—	—	$506.8M
Voyager Therapeutics, Inc. (VYGR)	$40.4M	—	—	$213.2M
SANGAMO THERAPEUTICS, INC (SGMOQ)	$39.6M	—	—	$66.3M
Kymera Therapeutics, Inc. (KYMR)	$39.2M	—	—	$9.89B
C4 Therapeutics, Inc. (CCCC)	$35.9M	—	—	$521.6M
X4 Pharmaceuticals, Inc (XFOR)	$35.1M	—	—	$400.6M
PRECISION BIOSCIENCES INC (DTIL)	$34.3M	—	—	$231.9M
Scilex Holding Co (SCLX)	$30.3M	—	—	$38.2M
Metagenomi Therapeutics, Inc. (MGX)	$25.2M	—	—	$45.0M
Alector, Inc. (ALEC)	$21.0M	—	—	$252.3M
LENZ Therapeutics, Inc. (LENZ)	$19.1M	—	—	$160.6M
Pelthos Therapeutics Inc. (PTHS)	$16.8M	—	—	$94.7M
Relay Therapeutics, Inc. (RLAY)	$15.4M	—	—	$4.11B
Lineage Cell Therapeutics, Inc. (LCTX)	$13.6M	—	—	$280.7M
ELUTIA INC. (ELUT)	$12.3M	—	1.0×	$38.1M
Caribou Biosciences, Inc. (CRBU)	$11.2M	—	—	$176.9M
TScan Therapeutics, Inc. (TCRX)	$10.3M	—	—	$45.2M
Alpha Cognition Inc. (ACOG)	$10.2M	—	—	$201.9M
Taysha Gene Therapies, Inc. (TSHA)	$9.8M	—	—	$1.88B
CURIS INC (CRIS)	$9.4M	-80.3%	—	$3.6M
FATE THERAPEUTICS INC (FATE)	$6.6M	—	—	$304.3M
DBV Technologies S.A. (DBVT)	$5.6M	—	—	$850.9M
CRISPR Therapeutics AG (CRSP)	$3.5M	—	—	$5.51B
Surrozen, Inc./DE (SRZN)	$3.5M	—	—	$263.5M
Artiva Biotherapeutics, Inc. (ARTV)	$0	—	—	$551.5M
Denali Therapeutics Inc. (DNLI)	$0	—	—	$3.80B
Revolution Medicines, Inc. (RVMD)	$0	—	—	$44.98B
Maze Therapeutics, Inc. (MAZE)	—	—	—	$1.59B

Popular comparisons

AMGN vs GILD AMGN vs MRNA AMGN vs RVMD AMGN vs BIIB AMGN vs NBIX AMGN vs EXEL AMGN vs TECH GILD vs MRNA All comparisons →

Other industries

Semiconductor Stocks Software Stocks Pharmaceutical Stocks REIT Stocks Bank Stocks Oil and Gas Stocks Insurance Stocks Medical Device Stocks Restaurant Stocks

Screen biotech stocks on fundamentals

Filter this industry by margin, growth and valuation, compare any two companies side by side, and ask their filings a question with cited answers.

Start free

Industry grouping is derived from each company’s SEC-assigned SIC code, which is self-reported and coarse: a company is placed by its primary declared line of business. Financial statements come from SEC EDGAR; valuation figures use market data. Informational only. Not investment advice.